Crystal structures of the active site mutant (Arg-243-->Ala) in the T and R allosteric states of pig kidney fructose-1,6-bisphosphatase expressed in Escherichia coli.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 2143480)

Published in Protein Sci on August 01, 1996

Authors

B Stec1, R Abraham, E Giroux, E R Kantrowitz

Author Affiliations

1: Department of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, Massachusetts 02167, USA.

Articles cited by this

The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol (1977) 90.57

ALLOSTERIC INHIBITION OF RAT LIVER FRUCTOSE 1,6-DIPHOSPHATASE BY ADENOSINE 5'-MONOPHOSPHATE. J Biol Chem (1965) 7.97

Calculation of electrostatic potentials in an enzyme active site. Nature (1987) 2.88

Complete amino acid sequence of pig kidney fructose-1,6-bisphosphatase. Proc Natl Acad Sci U S A (1982) 1.37

Crystallographic studies of the catalytic mechanism of the neutral form of fructose-1,6-bisphosphatase. Biochemistry (1993) 1.27

cDNA sequence of rat liver fructose-1,6-bisphosphatase and evidence for down-regulation of its mRNA by insulin. Proc Natl Acad Sci U S A (1988) 1.22

Conformational transition of fructose-1,6-bisphosphatase: structure comparison between the AMP complex (T form) and the fructose 6-phosphate complex (R form). Biochemistry (1991) 1.22

Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 6-phosphate, AMP, and magnesium. Proc Natl Acad Sci U S A (1990) 1.18

The effect of pH on the kinetics of beef-liver fructose bisphosphatase. Eur J Biochem (1975) 1.09

Hepatic gluconeogenesis/glycolysis: regulation and structure/function relationships of substrate cycle enzymes. Annu Rev Nutr (1991) 1.09

Crystal structure of the neutral form of fructose-1,6-bisphosphatase complexed with the product fructose 6-phosphate at 2.1-A resolution. Proc Natl Acad Sci U S A (1991) 0.97

Molecular structure of fructose-1,6-bisphosphatase at 2.8-A resolution. Proc Natl Acad Sci U S A (1989) 0.96

The allosteric site of human liver fructose-1,6-bisphosphatase. Analysis of six AMP site mutants based on the crystal structure. J Biol Chem (1994) 0.92

Allosteric transition of fructose-1,6-bisphosphatase. Proc Natl Acad Sci U S A (1993) 0.92

Isolation of a human liver fructose-1,6-bisphosphatase cDNA and expression of the protein in Escherichia coli. Role of ASP-118 and ASP-121 in catalysis. J Biol Chem (1993) 0.91

Crystal structure of spinach chloroplast fructose-1,6-bisphosphatase at 2.8 A resolution. Biochemistry (1995) 0.90

Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 2,6-bisphosphate, AMP, and Zn2+ at 2.0-A resolution: aspects of synergism between inhibitors. Proc Natl Acad Sci U S A (1994) 0.90

The allosteric properties of beef-liver fructose bisphosphatase. Eur J Biochem (1975) 0.90

Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography. Biochemistry (1995) 0.88

Isolation and sequence analysis of the cDNA for pig kidney fructose 1,6-bisphosphatase. Proc Natl Acad Sci U S A (1992) 0.83

Mutation of arginine 276 to methionine changes Mg2+ cooperativity and the kinetic mechanism of fructose-1,6-bisphosphatase. Biochemistry (1995) 0.80

Expression of rat liver fructose-1,6-bisphosphatase in Escherichia coli. Biochem Biophys Res Commun (1991) 0.80

Replacement of glutamic acid 29 with glutamine leads to a loss of cooperativity for AMP with porcine fructose-1,6-bisphosphatase. J Biol Chem (1994) 0.80

Lysine 274 is essential for fructose 2,6-bisphosphate inhibition of fructose-1,6-bisphosphatase. J Biol Chem (1992) 0.79

High-level expression of porcine fructose-1,6-bisphosphatase in Escherichia coli: purification and characterization of the enzyme. Biochem Biophys Res Commun (1993) 0.78

Site-specific mutagenesis of the metal binding sites of porcine fructose-1,6-bisphosphatase. Arch Biochem Biophys (1993) 0.77

Articles by these authors

(truncated to the top 100)

EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature (2000) 7.03

Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res (1994) 3.22

Cognitive impairment and dementia in neurocysticercosis: a cross-sectional controlled study. Neurology (2010) 2.66

Susceptibility locus for Alzheimer's disease on chromosome 10. Science (2000) 2.49

Is 'starting on time' useful (or useless) as a surrogate measure for 'surgical theatre efficiency'? Anaesthesia (2012) 2.06

Lysosomal changes in epithelial cells of the mouse thymus after hydrocortisone treatment. Histochemie (1969) 1.84

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci U S A (2001) 1.79

Factors affecting birthweights in Hindus, Moslems and Europeans. Br J Obstet Gynaecol (1984) 1.77

Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Infect Dis (1991) 1.72

Superproduction and rapid purification of Escherichia coli aspartate transcarbamylase and its catalytic subunit under extreme derepression of the pyrimidine pathway. J Biol Chem (1985) 1.65

Relationship between Fc receptors, antigen-binding sites on T and B cells, and H-2 complex-associated determinants. J Exp Med (1975) 1.58

An improved colorimetric assay for aspartate and ornithine transcarbamylases. Anal Biochem (1981) 1.58

Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling. Nature (1997) 1.54

Gastroplasty for morbid obesity: technique, complications and results in 60 cases. Br J Surg (1989) 1.53

The intubating Laryngeal Mask Airway as a guide to fibreoscopy. Anaesthesia (2001) 1.39

A revised mechanism for the alkaline phosphatase reaction involving three metal ions. J Mol Biol (2000) 1.37

Insights into the mechanisms of catalysis and heterotropic regulation of Escherichia coli aspartate transcarbamoylase based upon a structure of the enzyme complexed with the bisubstrate analogue N-phosphonacetyl-L-aspartate at 2.1 A. Proteins (1999) 1.37

A subpopulation of T cells bearing Fc receptors. J Immunol (1975) 1.35

Differences among Asian patients. Br Med J (Clin Res Ed) (1986) 1.34

Escherichia coli aspartate carbamoyltransferase: the probing of crystal structure analysis via site-specific mutagenesis. Protein Eng (1991) 1.23

A model of the transition state in the alkaline phosphatase reaction. J Biol Chem (1999) 1.22

Effect of hydrophobic detergent on lipid absorption in the rat and on lipid and sterol balance in the swine. Dig Dis Sci (1979) 1.13

An essential residue at the active site of aspartate transcarbamylase. J Biol Chem (1976) 1.12

Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry (2011) 1.11

Formation of myeloid bodies in rat liver lysosomes after chloroquine administration. Exp Mol Pathol (1968) 1.11

Function of arginine-166 in the active site of Escherichia coli alkaline phosphatase. Biochemistry (1988) 1.09

Three residues involved in binding and catalysis in the carbamyl phosphate binding site of Escherichia coli aspartate transcarbamylase. Biochemistry (1989) 1.08

The role of dietary silver in the production of liver necrosis in vitamin E-deficient rats. Exp Mol Pathol (1969) 1.08

Hepatic response to lysosomal effects of hypoxia, neutral red and chloroquine. Nature (1967) 1.08

Interaction of tetraiodofluorescein with aspartate transcarbamylase and its isolated catalytic and regulatory subunits. J Biol Chem (1975) 1.07

A comparison of two methods for measuring thermal thresholds in diabetic neuropathy. J Neurol Neurosurg Psychiatry (1989) 1.07

A bicarbonate ion as a general base in the mechanism of peptide hydrolysis by dizinc leucine aminopeptidase. Proc Natl Acad Sci U S A (1999) 1.06

Human peripheral blood Valpha24+ Vbeta11+ NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells. Vox Sang (2002) 1.06

Irreversible lysosomal damage induced by chloroquine in the retinae of pigmented and albino rats. Exp Mol Pathol (1970) 1.05

Association analysis of 528 intra-genic SNPs in a region of chromosome 10 linked to late onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 1.04

Spectrum of cognitive impairment in neurocysticercosis: differences according to disease phase. Neurology (2012) 1.04

Lysosomal changes associated with hyperoxia in the isolated perfused rat liver. Exp Mol Pathol (1968) 1.03

Copeland surface replacement of the shoulder. Results of an hydroxyapatite-coated cementless implant in patients over 80 years of age. J Bone Joint Surg Br (2007) 1.02

A possible model for the concerted allosteric transition in Escherichia coli aspartate transcarbamylase as deduced from site-directed mutagenesis studies. Biochemistry (1988) 1.00

Glutamic acid residue 98 is critical for catalysis in pig kidney fructose-1,6-bisphosphatase. Biochem Biophys Res Commun (1996) 1.00

Conversion of a magnesium binding site into a zinc binding site by a single amino acid substitution in Escherichia coli alkaline phosphatase. J Biol Chem (1993) 1.00

Effects of chronic chloroquine treatment on lysosomes of rat liver cells. Exp Mol Pathol (1970) 0.98

Evaluation of two standards of arm/head ratios in neonatal nutritional assessment. East Afr Med J (2000) 0.98

Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2010) 0.98

Analysis of two purified mutants of Escherichia coli aspartate transcarbamylase with single amino acid substitutions. J Mol Biol (1983) 0.98

The effect of bran on dimethylhydrazine-induced colon carcinogenesis in the rat. Proc Soc Exp Biol Med (1978) 0.97

Direct structural evidence for a concerted allosteric transition in Escherichia coli aspartate transcarbamoylase. Nat Struct Biol (2001) 0.97

Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Bone Marrow Transplant (2001) 0.96

Identification of a trans-acting regulatory factor involved in the control of the pyrimidine pathway in E. coli. Mol Gen Genet (1983) 0.96

Zn(II)-induced cooperativity of Escherichia coli ornithine transcarbamoylase. Proc Natl Acad Sci U S A (1982) 0.96

Trapping and visualization of a covalent enzyme-phosphate intermediate. Nat Struct Biol (1997) 0.95

Magnesium in the active site of Escherichia coli alkaline phosphatase is important for both structural stabilization and catalysis. Biochemistry (1993) 0.95

The conserved residues glutamate-37, aspartate-100, and arginine-269 are important for the structural stabilization of Escherichia coli aspartate transcarbamoylase. Biochemistry (1993) 0.95

Clinical standards for inpatient specialist rehabilitation services in the UK. Clin Rehabil (2000) 0.95

Relationship between domain closure and binding, catalysis, and regulation in Escherichia coli aspartate transcarbamylase. Biochemistry (1988) 0.94

Clinical standards for specialist community rehabilitation services in the UK. Clin Rehabil (2001) 0.93

Mutations at positions 153 and 328 in Escherichia coli alkaline phosphatase provide insight towards the structure and function of mammalian and yeast alkaline phosphatases. J Mol Biol (1995) 0.93

Kinetic and X-ray structural studies of three mutant E. coli alkaline phosphatases: insights into the catalytic mechanism without the nucleophile Ser102. J Mol Biol (1998) 0.92

Uptake and storage of degraded carrageenan in lysosomes of reticuloendothelial cells of the rhesus monkey, Macaca mulatta. Exp Mol Pathol (1972) 0.92

The mechanism of the alkaline phosphatase reaction: insights from NMR, crystallography and site-specific mutagenesis. FEBS Lett (1999) 0.92

The synergistic inhibition of Escherichia coli aspartate carbamoyltransferase by UTP in the presence of CTP is due to the binding of UTP to the low affinity CTP sites. J Biol Chem (1991) 0.92

Importance of domain closure for homotropic cooperativity in Escherichia coli aspartate transcarbamylase. Biochemistry (1990) 0.92

Involvement of tryptophan 209 in the allosteric interactions of Escherichia coli aspartate transcarbamylase using single amino acid substitution mutants. J Mol Biol (1986) 0.91

Structural consequences of the replacement of Glu239 by Gln in the catalytic chain of Escherichia coli aspartate transcarbamylase. J Mol Biol (1990) 0.90

Mutation of Arg-166 of alkaline phosphatase alters the thio effect but not the transition state for phosphoryl transfer. Implications for the interpretation of thio effects in reactions of phosphatases. Biochemistry (2000) 0.89

Reduced binding of added zinc in serum of patients with decompensated hepatic cirrhosis. Eur J Clin Invest (1977) 0.89

Cecal response to different molecular weights and types of carrageenan in the guinea pig. Toxicol Appl Pharmacol (1976) 0.89

The regulatory subunit of Escherichia coli aspartate carbamoyltransferase may influence homotropic cooperativity and heterotropic interactions by a direct interaction with the loop containing residues 230-245 of the catalytic chain. Proc Natl Acad Sci U S A (1990) 0.88

A single mutation in the regulatory chain of Escherichia coli aspartate transcarbamoylase results in an extreme T-state structure. J Mol Biol (1998) 0.88

A loop involving catalytic chain residues 230-245 is essential for the stabilization of both allosteric forms of Escherichia coli aspartate transcarbamylase. Biochemistry (1989) 0.88

The effect of chloroquine on rat heart lysosomes. J Ultrastruct Res (1969) 0.88

Determinants of the first decade of bone loss after menopause at spine, hip and radius. QJM (1999) 0.88

A cis-proline to alanine mutant of E. coli aspartate transcarbamoylase: kinetic studies and three-dimensional crystal structures. Biochemistry (2000) 0.87

Paternal effects of ethanol in the long-evans rat. J Toxicol Environ Health (1982) 0.87

Role of lysosomes in carrageenan-induced cecal ulceration. Gastroenterology (1974) 0.87

Importance of residues Arg-167 and Gln-231 in both the allosteric and catalytic mechanisms of Escherichia coli aspartate transcarbamoylase. Biochemistry (1990) 0.87

Function of arginine-234 and aspartic acid-271 in domain closure, cooperativity, and catalysis in Escherichia coli aspartate transcarbamylase. Biochemistry (1988) 0.87

Stroke in octogenarians undergoing coronary artery surgery with and without cardiopulmonary bypass. Ann Thorac Surg (2000) 0.87

Functionally important arginine residues of aspartate transcarbamylase. J Biol Chem (1977) 0.87

Characterization of the aspartate transcarbamoylase from Methanococcus jannaschii. J Biol Chem (2000) 0.87

Rate-determining step of Escherichia coli alkaline phosphatase altered by the removal of a positive charge at the active center. Biochemistry (1999) 0.87

Reversible inhibition of spermatogenesis in rats and monkeys with a new class of indazol-carboxylic acids. Exp Mol Pathol (1975) 0.86

Neurological deficit and canal compromise in thoracolumbar and lumbar burst fractures. J Orthop Surg (Hong Kong) (2008) 0.86

The contribution of individual interchain interactions to the stabilization of the T and R states of Escherichia coli aspartate transcarbamoylase. J Biol Chem (2000) 0.86

Comparison of the essential arginine residue in Escherichia coli ornithine and aspartate transcarbamylases. Biochim Biophys Acta (1981) 0.85

Conversion of the noncooperative Bacillus subtilis aspartate transcarbamoylase into a cooperative enzyme by a single amino acid substitution. Biochemistry (1992) 0.85

Kinetic and structural consequences of replacing the aspartate bridge by asparagine in the catalytic metal triad of Escherichia coli alkaline phosphatase. J Mol Biol (1996) 0.85

Lysine-60 in the regulatory chain of Escherichia coli aspartate transcarbamoylase is important for the discrimination between CTP and ATP. Biochemistry (1989) 0.85

Catalytic-regulatory subunit interactions and allosteric effects in aspartate transcarbamylase. J Biol Chem (1987) 0.84

An essential arginine residue in porcine phospholipiase A2. J Biol Chem (1980) 0.84

Why are mammalian alkaline phosphatases much more active than bacterial alkaline phosphatases? Mol Microbiol (1994) 0.84

Lysosomal dysfunction in colonic submucosal macrophages of rhesus monkeys caused by degraded iota carrageenan. Proc Soc Exp Biol Med (1975) 0.84

Dental post-operative sensitivity associated with a gallium-based restorative material. Br Dent J (2000) 0.84

A receptor for antibody on B lymphocytes. III. Relationship to immunoglobulin and ia determinants. Int Arch Allergy Appl Immunol (1976) 0.84

Arginine 54 in the active site of Escherichia coli aspartate transcarbamoylase is critical for catalysis: a site-specific mutagenesis, NMR, and X-ray crystallographic study. Protein Sci (1992) 0.83

Three of the six possible intersubunit stabilizing interactions involving Glu-239 are sufficient for restoration of the homotropic and heterotropic properties of Escherichia coli aspartate transcarbamoylase. J Biol Chem (2000) 0.83

Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer. Ann Oncol (1999) 0.83

Isolation and sequence analysis of the cDNA for pig kidney fructose 1,6-bisphosphatase. Proc Natl Acad Sci U S A (1992) 0.83

Propagation of allosteric changes through the catalytic-regulatory interface of Escherichia coli aspartate transcarbamylase. Biochemistry (1988) 0.83

Coronary artery vasculitis and myocardial infarction associated with antiphospholipid antibodies in a pregnant woman. Aust N Z J Med (1989) 0.83